A detailed history of Susquehanna International Group, LLP transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 202,850 shares of ANTX stock, worth $419,899. This represents 0.0% of its overall portfolio holdings.

Number of Shares
202,850
Previous 99,404 104.07%
Holding current value
$419,899
Previous $2.04 Million 67.63%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$2.78 - $21.53 $287,579 - $2.23 Million
103,446 Added 104.07%
202,850 $659,000
Q4 2023

Feb 14, 2024

BUY
$13.92 - $21.0 $1.05 Million - $1.58 Million
75,141 Added 309.69%
99,404 $2.04 Million
Q3 2023

Nov 14, 2023

BUY
$7.58 - $16.08 $183,913 - $390,149
24,263 New
24,263 $390,000
Q3 2022

Nov 14, 2022

SELL
$7.61 - $22.29 $77,561 - $227,179
-10,192 Reduced 37.72%
16,827 $292,000
Q2 2022

Aug 15, 2022

BUY
$7.7 - $18.82 $208,046 - $508,497
27,019 New
27,019 $209,000

Others Institutions Holding ANTX

About AN2 Therapeutics, Inc.


  • Ticker ANTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,402,700
  • Market Cap $40.2M
  • Description
  • AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...
More about ANTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.